BRIEF-Aurinia Pharmaceuticals Q4 Pretax Profit USD 1.173 Million

Reuters
27 Feb
BRIEF-Aurinia Pharmaceuticals Q4 Pretax Profit USD 1.173 Million

Feb 27 (Reuters) - Aurinia Pharmaceuticals Q4 net income USD 1.429 million.

  • Q4 operating income USD -1.669 million
  • Q4 product revenue USD 57.582 million
  • Q4 operating expenses USD 61.536 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10